Spin-off Companies
Prolysis Limited
Prolysis was founded in 1998 as an antibacterial drug discovery company. Professor J Errington FRS, FMedSci (Director of CBCB) was founder and Chief Scientific Officer of Prolysis. Professor Errington is currently a Non-Executive Director of Biota Holdings who acquired Prolysis in November 2009.
Demuris
Professor J Errington FRS, FMedSci (Director of CBCB) is founder and Scientific Director of the drug discovery company Demuris. Established in 2008, Demuris is focused on developing novel therapeutics (particularly anti-infectives) against a range of conditions.
Orla Protein Technologies
Professor J H Lakey is Scientific Director and founder of Orla Protein Technologies a bio-nanotechnology company specialising in manufacture of biosurfaces. In 2002 Orla was one of the winners in the BBSRC Biosciences Business Awards and has received two DTI Innovation Awards.
